Imaging of dopamine transporters with [123I]β-CIT SPECT in Parkinson' s disease and multiple system atrophy:: Comparison with clinical evaluation.

被引：0
|
作者：
Varrone, A
Marek, KL
Jennings, D
Innis, RB
Seibyl, JP
机构：
[1] Yale Univ, New Haven, CT USA
[2] VA Connecticut, W Haven, CT USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2000年 / 41卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
544
引用
收藏
页码：138P / 138P
页数：1
相关论文
共 50 条
  • [41] Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease
    Booij, J
    Habraken, JBA
    Bergmans, P
    Tissingh, G
    Winogrodzka, A
    Wolters, EC
    Janssen, AGM
    Stoof, JC
    van Royen, EA
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (11) : 1879 - 1884
  • [42] Extrastriatal [123I] FP-CIT uptake helps discriminate between Parkinson's disease and multiple system atrophy
    Eusebio, A.
    Guedj, E.
    Witjas, T.
    Mundler, O.
    Azulay, J. -P.
    MOVEMENT DISORDERS, 2011, 26 : S335 - S336
  • [43] Imaging of serotonin transporters with [123I]FP-CIT SPECT in the human hypothalamus
    Anke J Borgers
    Anneke Alkemade
    Elsmarieke M Van de Giessen
    Madeleine L Drent
    Jan Booij
    Peter H Bisschop
    Eric Fliers
    EJNMMI Research, 3
  • [44] Imaging of serotonin transporters with [123I]FP-CIT SPECT in the human hypothalamus
    Borgers, Anke J.
    Alkemade, Anneke
    Van de Giessen, Elsmarieke M.
    Drent, Madeleine L.
    Booij, Jan
    Bisschop, Peter H.
    Fliers, Eric
    EJNMMI RESEARCH, 2013, 3 : 1 - 7
  • [45] The role of [123I]-FP-CIT SPECT in the diagnosis and clinical management of Parkinson's Disease.
    Feggi, L. M.
    Panareo, S.
    Sensi, C.
    Fabbri, S.
    Casali, M.
    Fainardi, E.
    Cittanti, C.
    Giganti, M.
    Prandini, N.
    Bagatin, E.
    Costanzo, A.
    Mangherini, S.
    Preda, F.
    Quatrale, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S98 - S98
  • [46] [123I]FP-CIT imaging in patients with Parkinson's disease: The effect of dopamine agonist drugs
    Volterrani, Duccio
    Ceravolo, Roberto
    Manca, Gianpiero
    Filidei, Elena
    Chiacchio, Serena
    Guidoccio, Federica
    Frosini, Daniela
    Locantore, Luisa
    Mariani, Giuliano
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [47] The effect of dopamine agonist drugs on [123I]FP-CIT imaging in patients with Parkinson's Disease
    Volterrani, D.
    Ceravolo, R.
    Manca, G.
    Rossi, M.
    Kiferle, L.
    Rizza, E.
    Mattone, V.
    Pesella, F.
    Frosini, D.
    Murri, L.
    Bonuccelli, U.
    Mariani, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S112 - S112
  • [48] SPECT imaging of the dopamine transporter with [123I]-β-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction
    Sakakibara, R
    Shinotoh, H
    Uchiyama, T
    Yoshiyama, M
    Hattori, T
    Yamanishi, T
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 187 (1-2) : 55 - 59
  • [49] [I-123] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease
    Marek, KL
    Seibyl, JP
    Zoghbi, SS
    ZeaPonce, Y
    Baldwin, RM
    Fussell, B
    Charney, DS
    vanDyck, C
    Hoffer, PB
    Innis, RB
    NEUROLOGY, 1996, 46 (01) : 231 - 237
  • [50] Gait impairment in Parkinson's disease: an [123I]FP-CIT SPECT study
    Contreras, V. C. Suarez
    Tayyabah, Y.
    Caminiti, S. P.
    Politis, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 845 - 845
12345